Telsey Advisory analyst Dana Telsey lowered the firm’s price target on Zevia to $2 from $3 and keeps a Market Perform rating on the shares. The company’s Q1 results were “mixed,” with an inline sales decline of (10%) but a worse adjusted EBITDA, the analyst tells investors. Further, the company guided its Q2 and FY24 sales lower than anticipated, the firm adds. Altogether, the firm believes Zevia needs to improve its go-to-market strategy and execution in the near term.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZVIA: